Oscar Health, Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported net loss was USD 150.03 million compared to USD 226.05 million a year ago. Basic loss per share from continuing operations was USD 0.66 compared to USD 1.05 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.56 USD | -1.84% | +9.68% | +91.91% |
Mar. 22 | Raymond James Starts Oscar Health With Outperform Rating, $20 Price Target | MT |
Mar. 18 | Oscar Health, Inc.(NYSE:OSCR) added to S&P Insurance Select Industry Index | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+91.91% | 4.16B | |
+12.56% | 9.63B | |
+11.67% | 6.08B | |
-1.08% | 2.31B | |
-20.94% | 1.01B | |
+2.18% | 862M | |
+78.12% | 748M | |
+3.36% | 162M | |
-8.15% | 68.79M |
- Stock Market
- Equities
- OSCR Stock
- News Oscar Health, Inc.
- Oscar Health, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023